Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virus
- 1 November 2009
- journal article
- research article
- Published by Elsevier BV in Human Pathology
- Vol. 40 (11), 1517-1527
- https://doi.org/10.1016/j.humpath.2009.05.010
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Generation and characterization of a preventive and therapeutic HPV DNA vaccineVaccine, 2008
- Anal squamous intraepithelial lesions and condyloma in HIV-infected heterosexual men, homosexual men and women: prevalence and associated factorsAIDS, 2007
- Lapatinib: a dual inhibitor of EGFR and HER2 tyrosine kinase activityExpert Opinion on Biological Therapy, 2007
- Inhibition of Tumor Growth with Antiangiogenic Cancer Vaccine Using Epitope Peptides Derived from Human Vascular Endothelial Growth Factor Receptor 1Clinical Cancer Research, 2006
- Evaluation of epidermal growth factor receptor gene and chromosome 7 alterations in squamous cell carcinoma of the larynx, using chromogenic in situ hybridization on tissue microarraysThe Journal of Laryngology & Otology, 2006
- Tyrosine Kinase Inhibitors of Vascular Endothelial Growth Factor Receptors in Clinical Trials: Current Status and Future DirectionsThe Oncologist, 2006
- EGFR protein overexpression and gene amplification in squamous cell carcinomas of the esophagusInternational Journal of Cancer, 2005
- Epidermal Growth Factor Receptor Expression in Anal Canal CarcinomaAmerican Journal of Clinical Pathology, 2005
- The biology of VEGF and its receptorsNature Medicine, 2003
- The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells.The Journal of cell biology, 1993